Legend Biotech (NASDAQ: LEGN) reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $306.3 million versus the consensus estimate of $310.71 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.